Iranian Red Crescent Medical Journal

Published by: Kowsar

Serum Matrix Metalloproteinase Levels in Patients Exposed to Sulfur Mustard

Majid Shohrati 1 , * , Reza Haji Hosseini 2 , Malek Ashtar Esfandiari 2 , Nastaran Najafian 2 , Bita Najafian 3 and Abbas Golbedagh 2
Authors Information
1 Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
2 Department of Biochemistry, Payame Noor University, Tehran, IR Iran
3 Department of Pediatrics, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
Article information
  • Iranian Red Crescent Medical Journal: March 1, 2014, 16 (3); e15129
  • Published Online: March 5, 2014
  • Article Type: Research Article
  • Received: September 29, 2013
  • Revised: November 4, 2013
  • Accepted: December 7, 2013
  • DOI: 10.5812/ircmj.15129

To Cite: Shohrati M, Haji Hosseini R, Esfandiari M A, Najafian N, Najafian B, et al. Serum Matrix Metalloproteinase Levels in Patients Exposed to Sulfur Mustard, Iran Red Crescent Med J. 2014 ;16(3):e15129. doi: 10.5812/ircmj.15129.

Copyright: Copyright © 0, Iranian Red Crescent Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Ghanei M, Adibi I, Farhat F, Aslani J. Late respiratory effects of sulfur mustard: how is the early symptoms severity involved? Chron Respir Dis. 2008; 5(2): 95-100[DOI][PubMed]
  • 2. Ghanei M, Mokhtari M, Mohammad MM, Aslani J. Bronchiolitis obliterans following exposure to sulfur mustard: chest high resolution computed tomography. Eur J Radiol. 2004; 52(2): 164-9[DOI][PubMed]
  • 3. Shohrati M, Aslani J, Eshraghi M, Alaedini F, Ghanei M. Therapeutics effect of N-acetyl cysteine on mustard gas exposed patients: evaluating clinical aspect in patients with impaired pulmonary function test. Respir Med. 2008; 102(3): 443-8[DOI][PubMed]
  • 4. Yaraee R, Ghazanfari T, Ebtekar M, Ardestani SK, Rezaei A, Kariminia A, et al. Alterations in serum levels of inflammatory cytokines (TNF, IL-1alpha, IL-1beta and IL-1Ra) 20 years after sulfur mustard exposure: Sardasht-Iran cohort study. Int Immunopharmacol. 2009; 9(13-14): 1466-70[DOI][PubMed]
  • 5. Mautino G, Capony F, Bousquet J, Vignola AM. Balance in asthma between matrix metalloproteinases and their inhibitors. J Allergy Clin Immunol. 1999; 104(3 Pt 1): 530-3[PubMed]
  • 6. Shohrati M, Ghanei M, Shamspour N, Jafari M. Activity and function in lung injuries due to sulphur mustard. Biomarkers. 2008; 13(7): 728-33[DOI][PubMed]
  • 7. Karami A, Arjmand S, Khalilpour A, Beyrami JF, Ghaneei M, Eshraghi M. New p53 gene mutation in non-cancerous mustard gas exposed lung. Iran J Basic Med Sci. 2007; 10: 111-7
  • 8. Davoudi SM, Sadr B, Hayatbakhsh MR, Keshavarz S, Shohrati M, Naghizadeh MM, et al. Comparative study of skin sebum and elasticity level in patients with sulfur mustard-induced dermatitis and healthy controls. Skin Res Technol. 2010; 16(2): 237-42[DOI][PubMed]
  • 9. Shohrati M, Shamspour N, Babaei F, Harandi AA, Mohsenifar A, Aslani J, et al. Evaluation of activity and phenotype of alpha1-antitrypsin in a civil population with respiratory complications following exposure to sulfur mustard 20 years ago. Biomarkers. 2010; 15(1): 47-51[DOI][PubMed]
  • 10. Roderfeld M, Rath T, Schulz R, Seeger W, Tschuschner A, Graf J, et al. Serum matrix metalloproteinases in adult CF patients: Relation to pulmonary exacerbation. J Cyst Fibros. 2009; 8(5): 338-47[DOI][PubMed]
  • 11. Edkins TJ, Alhadeff JA, Kwok V, Kalensky C, Rock MT, Vidmar TJ, et al. Development and validation of novel enzyme activity methods to assess inhibition of matrix metalloproteinases (MMPs) in human serum by antibodies against enzyme therapeutics. J Pharm Biomed Anal. 2012; 70: 408-14[DOI][PubMed]
  • 12. Bellayr IH, Mu X, Li Y. Biochemical insights into the role of matrix metalloproteinases in regeneration: challenges and recent developments. Future Med Chem. 2009; 1(6): 1095-111[DOI][PubMed]
  • 13. Hopps E, Caimi G. Matrix metalloproteinases in metabolic syndrome. Eur J Intern Med. 2012; 23(2): 99-104[DOI][PubMed]
  • 14. Kim JM, Kang SW, Shin SM, Su Kim D, Choi KK, Kim EC, et al. Inhibition of matrix metalloproteinases expression in human dental pulp cells by all-trans retinoic acid. Int J Oral Sci. 2013; [DOI][PubMed]
  • 15. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol. 2001; 17: 463-516[DOI][PubMed]
  • 16. Allan JA, Docherty AJ, Barker PJ, Huskisson NS, Reynolds JJ, Murphy G. Binding of gelatinases A and B to type-I collagen and other matrix components. Biochem J. 1995; 309 ( Pt 1): 299-306[PubMed]
  • 17. Ordonez R, Carbajo-Pescador S, Prieto-Dominguez N, Garcia-Palomo A, Gonzalez-Gallego J, Mauriz JL. Inhibition of matrix metalloproteinase-9 and nuclear factor kappa B contribute to melatonin prevention of motility and invasiveness in HepG2 liver cancer cells. J Pineal Res. 2014; 56(1): 20-30[DOI][PubMed]
  • 18. Milia-Argeiti E, Huet E, Labropoulou VT, Mourah S, Fenichel P, Karamanos NK, et al. Imbalance of MMP-2 and MMP-9 expression versus TIMP-1 and TIMP-2 reflects increased invasiveness of human testicular germ cell tumours. Int J Androl. 2012; 35(6): 835-44[DOI][PubMed]
  • 19. Liu KC, Huang AC, Wu PP, Lin HY, Chueh FS, Yang JS, et al. Gallic acid suppresses the migration and invasion of PC-3 human prostate cancer cells via inhibition of matrix metalloproteinase-2 and -9 signaling pathways. Oncol Rep. 2011; 26(1): 177-84[DOI][PubMed]
  • 20. Zucker S, Doshi K, Cao J. Measurement of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMP) in blood and urine: potential clinical applications. Adv Clin Chem. 2004; 38: 37-85[PubMed]
  • 21. Sbardella D, Fasciglione GF, Gioia M, Ciaccio C, Tundo GR, Marini S, et al. Human matrix metalloproteinases: an ubiquitarian class of enzymes involved in several pathological processes. Mol Aspects Med. 2012; 33(2): 119-208[DOI][PubMed]
  • 22. Shohrati M, Ghanei M, Shamspour N, Babaei F, Abadi MN, Jafari M, et al. Glutathione and malondialdehyde levels in late pulmonary complications of sulfur mustard intoxication. Lung. 2010; 188(1): 77-83[DOI][PubMed]
  • 23. Hoshino M, Nakamura Y, Sim J, Shimojo J, Isogai S. Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation. J Allergy Clin Immunol. 1998; 102(5): 783-8[PubMed]
  • 24. Zuo F, Kaminski N, Eugui E, Allard J, Yakhini Z, Ben-Dor A, et al. Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proc Natl Acad Sci U S A. 2002; 99(9): 6292-7[DOI][PubMed]
  • 25. Imai K, Dalal SS, Chen ES, Downey R, Schulman LL, Ginsburg M, et al. Human collagenase (matrix metalloproteinase-1) expression in the lungs of patients with emphysema. Am J Respir Crit Care Med. 2001; 163(3 Pt 1): 786-91[DOI][PubMed]
  • 26. Kiani A, Mostafaie A, Shirazi FH, Ghazanfari T. Serum profiles of matrix metalloproteinases and their tissue inhibitors in long-term pulmonary complication induced by sulfur mustard: Sardasht-Iran Cohort Study (SICS). Int Immunopharmacol. 2013; 17(3): 964-7[DOI][PubMed]
  • 27. La Rocca G, Anzalone R, Magno F, Farina F, Cappello F, Zummo G. Cigarette smoke exposure inhibits extracellular MMP-2 (gelatinase A) activity in human lung fibroblasts. Respir Res. 2007; 8: 23[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader